Tag: Julien Freitag
TGA grants stem cell manufacturing licence to Magellan Stem Cells
Melbourne-based biotechnology company Magellan Stem Cells has secured a manufacturing licence from the Therapeutic Goods Administration (TGA), a move expected to reduce Australia’s reliance on overseas bio-tech manufacturers and bolster local research into stem cell therapies.
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
